IPVS webinar – HPV-Related Head and Neck Cancers: Epidemiology, novel therapeutics and impact
IPVS webinar – HPV-Related Head and Neck Cancers: Epidemiology, novel therapeutics and impact Thursday, July 27, 2023 16:00 – 17:00 CEST (Geneva) / 10:00 – 11:00 EDT (New York) Topic: Join us on July 27th to commemorate World Head and Neck Cancer Day with an important and free webinar. We will delve into critical aspects […]
IPVS webinar – HPV vaccine schedules and Sub-Saharan Africa
IPVS webinar – HPV vaccine schedules and Sub-Saharan Africa Monday, 24th January 2022 12:00-13:30 EST (New York) / 18:00-19:30 CET (Geneva) Topic: Sub Saharan Africa (SSA) has a very high burden of cervical cancer. HPV vaccines are being introduced in many countries in the region but there are many challenges in implementation for the adolescent […]
IPVS webinar: HPV pathobiology – lessons learned from mice
IPVS webinar: HPV pathobiology – lessons learned from mice Wednesday, 23rd February 2022 10:00 EST (New York) / 16:00 CET (Geneva) Moderator: Neil Christensen Professor Penn State University, College of Medicine Speakers: Megan Spurgeon Ph.D. University of Wisconsin School of Medicine and Public Health Richard Roden Professor Johns Hopkins University Topic: During this webinar, […]
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses
IPVS webinar – Highlights of the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses Wednesday, 23rd March 2022 12:00-13:00 EDT (New York) / 17:00-18:00 CET (Geneva) Topic: Have you missed the 2021 NCI Workshop on Antiviral Drug Development for Human Papillomaviruses or would you like to learn more about HPV antiviral drugs? Join […]
IPVS webinar: Everything you need to know about HPV and pregnancy
IPVS webinar: Everything you need to know about HPV and pregnancy Thursday, 28th April 2022 12:00-13:30 EDT (New York) / 18:00-19:30 CEST (Geneva) Topic: Join our upcoming webinar to learn everything you need to know about HPV and pregnancy. HPV lesion treatment is known to be associated with obstetrical complications and now HPV infection in […]
IPVS webinar – WHO recommendations on HPV vaccine schedule optimization
IPVS webinar – Update on WHO recommendations on HPV vaccine schedule optimization and implications for the field Wednesday, 22 February 2023 15:00 – 16:00 CET (Geneva) / 9:00 – 10:00 EST (New York) Topic: Join this live and free webinar for discussions on global policy on HPV vaccination and implementation considerations. Get the latest updates […]
IPVS webinar – The Future of HPV research
IPVS webinar – The Future of HPV research, featuring IPVS early career recognition awardee 2023 Tuesday, May 16, 2023 8:00 – 9:00 PDT (Los Angeles) / 17:00 – 18:00 CEST (Geneva) Topic: Join this educational webinar to hear the IPVS early career recognition awardee share her exceptional research. This will be followed by a 35-minute […]
IPVS webinar – IPVC 2023 in 60 minutes (Part 1)
IPVS webinar – IPVC 2023 in 60 minutes (Part 1): Birds eye view of conference highlights Wednesday, June 7, 2023 16:30 – 17:30 CEST (Geneva) / 10:30 – 11:30 EDT (New York) Topic: Did you miss IPVC 2023 in Washington DC (April 17-21, 2023)? Or you were probably unable to attend all sessions of the […]
IPVS webinar – IPVC 2023 in 60 minutes (Part 2)
IPVS webinar IPVC 2023 in 60 minutes (Part 2): Highlights from the workshops – state of the science Thursday, June 22, 2023 16:30 – 17:30 CEST (Geneva) / 10:30 – 11:30 EDT (New York) Topic: In this exciting free webinar, we will be focusing on the workshops that occurred during the IPV conference held last […]
IPVS webinar – HPV latency: more questions than answers
IPVS webinar – HPV latency: more questions than answers Wednesday, 29th September 2021 10:00 EDT (New York) / 16:00 CEST (Geneva) Topic: The ability of papillomaviruses to establish infection at human epithelial sites that is largely undetectable by most routine molecular diagnostic tests is indisputable. However, there remains considerable disagreement about what this ‘test negative, […]
